Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M, Cihova M, Buocikova V, Slopovsky J, Dubovan P, Pindak D, Tomas M, García-Bermejo L, Rodríguez-Garrote M, Earl J, Kohl Y, Kataki A, Dusinska M, Sainz B Jr, Smolkova B, Gabelova A. Urbanova M, et al. Among authors: buocikova v. Biomed Pharmacother. 2023 Sep;165:115179. doi: 10.1016/j.biopha.2023.115179. Epub 2023 Jul 21. Biomed Pharmacother. 2023. PMID: 37481927 Free article. Review.
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.
Buocikova V, Rios-Mondragon I, Pilalis E, Chatziioannou A, Miklikova S, Mego M, Pajuste K, Rucins M, Yamani NE, Longhin EM, Sobolev A, Freixanet M, Puntes V, Plotniece A, Dusinska M, Cimpan MR, Gabelova A, Smolkova B. Buocikova V, et al. Cancers (Basel). 2020 Dec 3;12(12):3622. doi: 10.3390/cancers12123622. Cancers (Basel). 2020. PMID: 33287297 Free PMC article. Review.
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova V, Longhin EM, Pilalis E, Mastrokalou C, Miklikova S, Cihova M, Poturnayova A, Mackova K, Babelova A, Trnkova L, El Yamani N, Zheng C, Rios-Mondragon I, Labudova M, Csaderova L, Kuracinova KM, Makovicky P, Kucerova L, Matuskova M, Cimpan MR, Dusinska M, Babal P, Chatziioannou A, Gabelova A, Rundén-Pran E, Smolkova B. Buocikova V, et al. Biomed Pharmacother. 2022 Mar;147:112662. doi: 10.1016/j.biopha.2022.112662. Epub 2022 Jan 25. Biomed Pharmacother. 2022. PMID: 35091237 Free article.
Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.
Smolkova B, Kataki A, Earl J, Ruz-Caracuel I, Cihova M, Urbanova M, Buocikova V, Tamargo S, Rovite V, Niedra H, Schrader J, Kohl Y. Smolkova B, et al. Among authors: buocikova v. Crit Rev Oncol Hematol. 2022 Dec;180:103865. doi: 10.1016/j.critrevonc.2022.103865. Epub 2022 Nov 2. Crit Rev Oncol Hematol. 2022. PMID: 36334880 Free article. Review.
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue.
Díaz-Alejo JF, April-Monn S, Cihova M, Buocikova V, Villalón López J, Urbanova M, Lechuga CG, Tomas M, Dubovan P, Sánchez BL, Páez SC, Sanjuanbenito A, Lobo E, Romio de la Heras E, Guerra C, de la Pinta C, Barreto Melian E, Rodríguez Garrote M, Carrato A, Ruiz-Cañas L, Sainz B Jr, Torres A, Smolkova B, Earl J. Díaz-Alejo JF, et al. Among authors: buocikova v. J Vis Exp. 2023 May 26;(195). doi: 10.3791/65229. J Vis Exp. 2023. PMID: 37306424
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression.
Buocikova V, Tyciakova S, Pilalis E, Mastrokalou C, Urbanova M, Matuskova M, Demkova L, Medova V, Longhin EM, Rundén-Pran E, Dusinska M, Rios-Mondragon I, Cimpan MR, Gabelova A, Soltysova A, Smolkova B, Chatziioannou A. Buocikova V, et al. Front Pharmacol. 2022 Oct 5;13:991751. doi: 10.3389/fphar.2022.991751. eCollection 2022. Front Pharmacol. 2022. PMID: 36278182 Free PMC article.
A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I. Zmetakova I, et al. Among authors: buocikova v. Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18. Cancer Sci. 2019. PMID: 30815959 Free PMC article.
Impact of interleukin 13 (IL13) genetic polymorphism Arg130Gln on total serum immunoglobulin (IgE) levels and interferon (IFN)-γ gene expression.
Smolkova B, Tulinska J, Palkovicova Murinova L, Buocikova V, Liskova A, Rausova K, Kuricova M, Patayova H, Sustrova M, Neubauerova Svorcova E, Ilavska S, Szabova M, Nemessanyi T, Jahnova E, Dusinska M, Ciznar P, Fuortes L. Smolkova B, et al. Among authors: buocikova v. Clin Exp Immunol. 2017 Apr;188(1):45-52. doi: 10.1111/cei.12923. Epub 2017 Feb 7. Clin Exp Immunol. 2017. PMID: 28054352 Free PMC article.
Genetic determinants of quantitative traits associated with cardiovascular disease risk.
Smolková B, Bonassi S, Buociková V, Dušinská M, Horská A, Kuba D, Džupinková Z, Rašlová K, Gašparovič J, Slíž I, Ceppi M, Vohnout B, Wsólová L, Volkovová K. Smolková B, et al. Among authors: buocikova v. Mutat Res. 2015 Aug;778:18-25. doi: 10.1016/j.mrfmmm.2015.05.005. Epub 2015 May 15. Mutat Res. 2015. PMID: 26043189
15 results